CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in RARE — Ultragenyx Pharmaceutical Inc.
CIK 884546
SAN FRANCISCO, CA
Position in RARE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,377,702
+$13,677,421 QoQ
Shares Held
760,039
+36.1% QoQ
Ownership
0.771%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. RARE ranks #59 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in RARE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,377,702 | 760,039 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,700,281 | 558,486 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,775,252 | 598,924 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $18,052,812 | 600,160 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $22,396,632 | 615,969 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $21,476,911 | 593,121 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $25,815,540 | 613,633 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $33,025,641 | 594,521 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $22,096,017 | 537,616 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $22,615,748 | 484,381 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $22,562,671 | 471,825 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $14,143,246 | 396,725 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $17,401,988 | 377,238 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $14,875,576 | 370,962 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $17,247,454 | 372,274 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,119,039 | 365,106 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $32,880,177 | 551,126 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $39,268,829 | 540,744 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $44,246,728 | 526,183 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $46,344,041 | 513,849 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $47,398,580 | 497,101 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $68,251,213 | 599,431 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $75,205,419 | 543,274 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $40,453,424 | 492,194 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $29,316,230 | 374,792 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $15,243,888 | 343,099 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||